A Food and Drug Administration (FDA)  advisory panel recommended Zavesca to treat NPC.  Phil Marella of DART, Cindy Parseghian of the Parseghian Foundation and Barb Vorpahl of the NNPDF spoke during the public portion of the hearing. The panel of…